Back to Trades
ODONNELL FRANCIS E JR
Chief Executive OfficerDirector10% OwnerCIK 0001066040
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
ODONNELL FRANCIS E JR, Chief Executive Officer, Director, 10% Owner, has filed 1 SEC report (2026), all concentrated in Inhibitor Therapeutics, Inc. (INTI), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Aug 4 | INTI Inhibitor Therapeutics, Inc. | ODONNELL FRANCIS E JR | Chief Executive Officer, Director, 10% Owner | Grant | $0 |
1 filing